Question 1

Which works better for weight loss, Ozempic or Foundayo?

Accepted Answer

Ozempic recorded -6.5 kg / 40 wk (SUSTAIN-7, 1 mg, T2D); Foundayo recorded -11.1% body weight / 72 wk (ATTAIN-1, 17.2 mg, obesity). ⚠ These come from separate trials with different protocols and populations, so the gap between two numbers from two studies is weaker evidence than it looks. No head-to-head trial of this pair is on record here.

Question 2

Are Ozempic and Foundayo the same drug?

Accepted Answer

No. Ozempic is semaglutide and Foundayo is orforglipron — different molecules, and they work differently: Peptide GLP-1 receptor agonist against Non-peptide small-molecule GLP-1 receptor agonist. Results with one do not predict results with the other.

Question 3

Is Ozempic or Foundayo cheaper?

Accepted Answer

On the manufacturers' own cash pricing: Ozempic at About $998/mo retail, with no manufacturer cash program, Foundayo at Launched April 2026; direct-pay pricing was still settling. ⚠ That is the list-price comparison, and it is not what most people pay. What you actually pay depends on whether your plan covers it, which formulary tier it sits in, and whether you have met your deductible — and for many people the honest comparison is between an insured copay and a cash-pay compounded alternative rather than between these two figures.

Question 4

What does a compounded version of each actually cost?

Accepted Answer

Across the 556 sellers in this register, the cheapest standing monthly cash prices we hold are semaglutide from $79 a month and orforglipron from $149 a month. ⛔ A compounded preparation is not the approved product: no agency has reviewed that specific preparation for safety, effectiveness or manufacturing quality, and the legal ground under compounding these molecules narrowed once the shortages closed. The price gap is real and so is the difference in oversight.

Question 5

Can I switch from Ozempic to Foundayo?

Accepted Answer

Yes, with a prescriber. Expect to re-titrate from the bottom of the new drug's ladder rather than starting where you left off: these are different molecules and tolerance to one does not transfer to the other. Both the old drug's washout and the new drug's schedule apply.

Question 6

Which one should I ask for?

Accepted Answer

That is a prescriber's call, and anyone answering it from a table is guessing. What a page like this can do is tell you what the trials measured, what the manufacturers charge, and where the evidence is still missing, so the conversation starts from the record rather than from an advertisement.

Field	Ozempic	Foundayo
Route & frequency	Subcutaneous injection, once weekly	Oral tablet, once daily (any time, with or without food)
Mechanism	Peptide GLP-1 receptor agonist	Non-peptide small-molecule GLP-1 receptor agonist
FDA-approved indication	Type 2 diabetes; CV risk reduction in T2D + established CVD	Chronic weight management (2025); T2D pending (ACHIEVE-1 filed)
A1C reduction (T2D)	-1.5% / 40 wk (SUSTAIN-7, 1 mg vs dulaglutide)	-1.3% to -1.6% / 40 wk (ACHIEVE-1, 17.2 mg)
Weight loss (pivotal trial)	-6.5 kg / 40 wk (SUSTAIN-7, 1 mg, T2D)	-11.1% body weight / 72 wk (ATTAIN-1, 17.2 mg, obesity)
Whether a trial proved it prevents heart attacks and strokes	SUSTAIN-6 cut major cardiac events 26%	None. No outcomes trial has reported
What it costs if you pay cash	About $998/mo retail, with no manufacturer cash program	Launched April 2026; direct-pay pricing was still settling
The complaint people report most	Nausea, around 20% at the 1 mg dose	Nausea, roughly 20-30% and rising with dose

Ozempic vs Foundayo: Old Injection, New Pill

The verdict

Side-by-side comparison

What each one costs in the compounded market

Frequently asked questions